CVS Health Corporation $CVS Position Boosted by Bank of New York Mellon Corp

Bank of New York Mellon Corp lifted its position in CVS Health Corporation (NYSE:CVS) by 6.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,110,576 shares of the pharmacy operator’s stock after buying an additional 577,064 shares during the quarter. Bank of New York Mellon Corp’s holdings in CVS Health were worth $723,015,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Greenwich Wealth Management LLC lifted its holdings in CVS Health by 4.3% in the 4th quarter. Greenwich Wealth Management LLC now owns 24,644 shares of the pharmacy operator’s stock worth $1,956,000 after purchasing an additional 1,012 shares during the last quarter. Heritage Trust Co lifted its holdings in CVS Health by 9.3% in the 4th quarter. Heritage Trust Co now owns 50,893 shares of the pharmacy operator’s stock worth $4,039,000 after purchasing an additional 4,343 shares during the last quarter. Root Financial Partners LLC lifted its holdings in CVS Health by 2.9% in the 4th quarter. Root Financial Partners LLC now owns 5,610 shares of the pharmacy operator’s stock worth $445,000 after purchasing an additional 160 shares during the last quarter. BNP Paribas lifted its holdings in CVS Health by 293.2% in the 4th quarter. BNP Paribas now owns 10,224 shares of the pharmacy operator’s stock worth $811,000 after purchasing an additional 7,624 shares during the last quarter. Finally, Collar Capital Management LLC lifted its holdings in CVS Health by 0.9% in the 4th quarter. Collar Capital Management LLC now owns 17,010 shares of the pharmacy operator’s stock worth $1,350,000 after purchasing an additional 145 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several analyst reports. Argus boosted their target price on CVS Health from $90.00 to $104.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. TD Cowen boosted their target price on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Morgan Stanley boosted their target price on CVS Health from $93.00 to $106.00 and gave the stock an “overweight” rating in a report on Thursday, May 14th. Deutsche Bank Aktiengesellschaft boosted their target price on CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, Robert W. Baird boosted their target price on CVS Health from $92.00 to $94.00 and gave the stock an “outperform” rating in a report on Wednesday, April 15th. Twenty-two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $99.68.

CVS Health Stock Performance

Shares of NYSE CVS opened at $91.61 on Thursday. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. The business’s 50 day moving average is $83.21 and its two-hundred day moving average is $79.79. The company has a market cap of $116.89 billion, a P/E ratio of 40.36, a P/E/G ratio of 0.88 and a beta of 0.62. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $98.43.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, topping the consensus estimate of $2.21 by $0.36. The company had revenue of $100.43 billion for the quarter, compared to the consensus estimate of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the previous year, the business posted $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, equities analysts expect that CVS Health Corporation will post 7.44 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, May 4th. Shareholders of record on Thursday, April 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s payout ratio is currently 117.18%.

Insider Buying and Selling

In other news, EVP Tilak Mandadi sold 69,551 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the sale, the executive vice president directly owned 10,133 shares in the company, valued at approximately $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Larry Robbins sold 370,462 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $93.45, for a total value of $34,619,673.90. Following the sale, the director owned 4,824,799 shares in the company, valued at approximately $450,877,466.55. This represents a 7.13% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 3,441,551 shares of company stock worth $323,703,977. 0.85% of the stock is currently owned by company insiders.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.